PlexusDx review

The commercial terms are the friendliest here for someone testing a low dose: month-to-month, no commitment tier at all, no membership, and a flat-price-at-every-dose guarantee stated for the microdose specifically rather than only for the standard products — a distinction most of this category leaves deliberately vague. The trade is that you cannot know what you are buying. That one price covers semaglutide or tirzepatide, oral or injectable, with the clinician selecting after your payment is authorized, and no milligram strength is published at any point.

Vs median

$46/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

PlexusDx says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

PlexusDx, Inc. runs a storefront pairing prescription telehealth protocols with consumer genetic and blood testing, selling seven weight-loss protocols — a microdose GLP-1, semaglutide and tirzepatide in injection and oral form, and a combination product — alongside peptide protocols, genetic test kits and at-home blood panels. It states plainly that it is not a medical practice or pharmacy: clinical services come from an independent network of U.S.-licensed clinicians on a state-licensed telehealth platform, medication from a licensed 503A compounding pharmacy, and medication and clinical fees are billed by the practice-management platform behind the prescribing clinicians rather than by PlexusDx. Every GLP-1 protocol is all-inclusive with no membership fee, available in all 50 states with five requiring a scheduled video consult.

You cannot know what molecule the $129 buys. One microdose price covers four different products — semaglutide or tirzepatide, oral or injection — and the clinician selects from them after payment is authorized, so the buyer commits before the drug is chosen

• No milligram strength is published for the microdose at any point, only "low-dose strengths" and "provider determined"
• The storefront's own add-to-cart price for standard semaglutide is the six-month commitment rung while the FAQ states a month-to-month rate $40 higher, and the identical gap exists on tirzepatide
• The live microdose product page renders an unreleased internal editorial note inside the pricing block, between the price and the call to action
• The microdose is the only GLP-1 protocol with no multi-month discount tier, so a microdose buyer cannot reach the per-month prices a standard-dose buyer can
• PlexusDx does not bill the medication itself — its terms put the charge with an unnamed practice-management platform, which is the counterparty on your card and not the brand you bought from
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

PlexusDx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Microdosing tirzepatide
• What a flat price costs at a low dose
• Microdose & reconstitution calculator